CHMP approves MDVN’s Xtandi for pre-chemo CRPC: http://finance.yahoo.com/news/xtandi-enzalutamide-capsules-receive-positive-130600800.html Rubber-stamped approval for EU marketing will follow in 2-3 months. FDA approved Xtandi in this indication on 9/10/14 (#msg-106140201).